Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

The spatial distribution of age-related white matter changes as a function of vascular risk factors—Results from the LADIS study

(2012) E. Rostrup et al.   NEUROIMAGE

Neuropathological background of phenotypical variability in frontotemporal dementia

(2011) Keith A. Josephs et al.   ACTA NEUROPATHOLOGICA

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Novel Types of Frontotemporal Lobar Degeneration: Beyond Tau and TDP-43

(2011) Ian R. A. Mackenzie et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes

(2011) Sara Bech et al.   PARKINSONISM & RELATED DISORDERS

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

(2010) Hazel Urwin et al.   ACTA NEUROPATHOLOGICA

Biomarkers in Alzheimer's disease drug development

(2010) Kaj Blennow   NATURE MEDICINE

Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease

(2009) Manuela Neumann et al.   ACTA NEUROPATHOLOGICA

Clinicopathological Concordance in Dementia Diagnostics

(2009) Hans Brunnström et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

A new subtype of frontotemporal lobar degeneration with FUS pathology

(2009) M. Neumann et al.   BRAIN

Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis

(2009) L. Fialová et al.   EUROPEAN JOURNAL OF NEUROLOGY

Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

(2008) Takashi Kasai et al.   ACTA NEUROPATHOLOGICA